Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial assessing the safety and preliminary efficacy of HB0025 injection in patients with advanced solid tumors, including advanced non-smal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• HB0025

Snippet

Sponsor: Huabo Biopharm Co., Ltd. | Conditions: Advanced NSCLC, Advanced Endometrial Cancer | Phase 1, Phase 2 | Status: RECRUITING